NL-OMON55112尚未招募3 期
Multicenter, Open-label, Efficacy, Safety, Tolerability, and Pharmacokinetic Study of Subcutaneous Ixekizumab with Adalimumab Reference Arm, in Children with Juvenile Idiopathic Arthritis Subtypes of Enthesitis-related Arthritis (Including Juvenile-Onset Ankylosing Spondylitis) and Juvenile Psoriatic Arthritis - I1F-MC-RHCG
适应症
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 入组人数
- 9
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 2 至 17(—)
入选标准
- •-Participants must have active juvenile idiopathic arthritis (categories of
- •XML File Identifier: Ie7xYHwCz5AAtrp51Ac/ZIiKACw=
- •enthesitis related arthritis or juvenile psoriatic arthritis)
- •Participants must have weight of at least 10 kilograms (Kg), age
- •starting at 2 years for participants with juvenile psoriatic arthritis and
- •starting at 6 years for participants with enthesitis related arthritis
- •Participants must have all immunizations up-to-date in agreement
- •with current immunization guidelines, in the opinion of the investigator
排除标准
- •- Participants must not have active or history of inflammatory bowel disease
- •? Participants must not have active uveitis
- •? Participants must not have active or latent tuberculosis
- •? Participants must not have an active infection
- •? Participants must not have concurrent use of biologic agents for the
- •treatment of the juvenile idiopathic arthritis
研究者
相似试验
进行中(未招募)
1 期
An Ixekizumab study with Adalimumab reference arm in children and young adults with Juvenile Idiopathic Arthritis Subtypes of Enthesitis-related ArthritisJuvenile Idiopathic Arthritis subtypes of enthesitis-related arthritis (including juvenile-onset ankylosing spondylitis) and juvenile psoriatic arthritisMedDRA version: 23.1Level: PTClassification code 10059176Term: Juvenile idiopathic arthritisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersEUCTR2018-000681-10-BEEli Lilly and Company100
进行中(未招募)
1 期
An Ixekizumab study with Adalimumab reference arm in children and young adults with Juvenile Idiopathic Arthritis Subtypes of Enthesitis-related ArthritisJuvenile Idiopathic Arthritis subtypes of enthesitis-related arthritis (including juvenile-onset ankylosing spondylitis) and juvenile psoriatic arthritisMedDRA version: 21.0Level: PTClassification code 10059176Term: Juvenile idiopathic arthritisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersEUCTR2018-000681-10-GBEli Lilly and Company100
进行中(未招募)
1 期
An Ixekizumab study with Adalimumab reference arm in children and young adults with Juvenile Idiopathic Arthritis Subtypes of Enthesitis-related ArthritisJuvenile Idiopathic Arthritis subtypes of enthesitis-related arthritis (including juvenile-onset ankylosing spondylitis) and juvenile psoriatic arthritisMedDRA version: 23.1Level: PTClassification code 10059176Term: Juvenile idiopathic arthritisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersEUCTR2018-000681-10-DEEli Lilly and Company100
进行中(未招募)
1 期
An Ixekizumab study with Adalimumab reference arm in children and young adults with Juvenile Idiopathic Arthritis Subtypes of Enthesitis-related ArthritisJuvenile Idiopathic Arthritis subtypes of enthesitis-related arthritis (including juvenile-onset ankylosing spondylitis) and juvenile psoriatic arthritisMedDRA version: 23.1Level: PTClassification code 10059176Term: Juvenile idiopathic arthritisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersEUCTR2018-000681-10-CZEli Lilly and Company100
进行中(未招募)
1 期
An Ixekizumab study with Adalimumab reference arm in children and young adults with Juvenile Idiopathic Arthritis Subtypes of Enthesitis-related ArthritisJuvenile Idiopathic Arthritis subtypes of enthesitis-related arthritis (including juvenile-onset ankylosing spondylitis) and juvenile psoriatic arthritisMedDRA version: 21.0Level: PTClassification code 10059176Term: Juvenile idiopathic arthritisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersEUCTR2018-000681-10-FREli Lilly and Company100
